发明授权
US07205409B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
有权
药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
- 专利标题： Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
- 专利标题（中）： 药物组合物作为二肽基肽酶-IV（DPP-IV）的抑制剂
-
申请号： US10935053申请日： 2004-09-07
-
公开(公告)号： US07205409B2公开(公告)日： 2007-04-17
- 发明人: Zhonghua Pei , Xiaofeng Li , Kenton L. Longenecker , Hing L. Sham , Paul E. Wiedeman
- 申请人： Zhonghua Pei , Xiaofeng Li , Kenton L. Longenecker , Hing L. Sham , Paul E. Wiedeman
- 申请人地址： US IL Abbott Park
- 专利权人： Abbott Laboratories
- 当前专利权人： Abbott Laboratories
- 当前专利权人地址： US IL Abbott Park
- 代理商 Andrew Parial; Johana Corbin
- 主分类号： C07D215/38
- IPC分类号： C07D215/38 ; C07D295/00
摘要：
The present invention relates to compounds of formula (I), which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, syndrome X, hyperinsulinemia, β-cell failure, obesity, satiety disorders, atherosclerosis, and various immunomodulatory diseases.
公开/授权文献
信息查询
